0001181431-12-057476.txt : 20121107
0001181431-12-057476.hdr.sgml : 20121107
20121107191711
ACCESSION NUMBER: 0001181431-12-057476
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121105
FILED AS OF DATE: 20121107
DATE AS OF CHANGE: 20121107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahatme Sandesh
CENTRAL INDEX KEY: 0001511034
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 121188116
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: OR
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 425-354-5038
MAIL ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
rrd359839.xml
FORM 4
X0306
4
2012-11-05
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001511034
Mahatme Sandesh
C/O SAREPTA THERAPEUTICS, INC.
3450 MONTE VILLA PARKWAY, SUITE 101
BOTHELL
WA
98021
0
1
0
0
Senior Vice President, CFO
Stock Option (right to buy)
23.85
2012-11-05
4
A
0
150000
0.00
D
2022-11-05
Common Stock
150000
150000
D
Stock Appreciation Right
23.85
2012-11-05
4
A
0
100000
0.00
D
2022-11-05
Common Stock
100000
100000
D
25% of the shares subject to the option vest on the first anniversary measured from November 5, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
25% of the shares subject to the stock appreciation right (the "SAR") vest on the first anniversary measured from November 5, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the SAR will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
/s/ Sandesh Mahatme
2012-11-07